Clinical Trial

Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects

Name: Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects — clinical trial record (NCT07558967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This study evaluated the bioequivalence and safety of the test formulation (Tenofovir Disoproxil Fumarate Tablets, Haisco Pharmaceutical Group Co., Ltd.) and the reference formulation (Viread®, Gilead Sciences, Inc.) in healthy Chinese subjects under fasting and fed conditions

Trial Details

NCT Number	NCT07558967
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Healthy
Enrollment	47 participants
Start Date	2017-06-20
Primary Completion	2017-08-23 (estimated)
Study Completion	2017-11-20 (estimated)
Updated on ClinicalTrials.gov	2026-04-30